<DOC>
	<DOCNO>NCT00552760</DOCNO>
	<brief_summary>The purpose study determine whether treat sleep difficulty patient bipolar disorder also improve mood stability .</brief_summary>
	<brief_title>Ramelteon Treatment Insomnia Mood Stability Patients With Euthymic Bipolar Disorder</brief_title>
	<detailed_description>Patients euthymic bipolar disorder , although free significant mood symptom , often continued sleep disturbance . Improving patient ' sleep also normalize circadian rhythm lead few mood exacerbation . Ramelteon offer new pharmacologically exact mechanism re-synchronize SCN . The administration ramelteon bipolar patient improve sleep cause few mood exacerbation . Patients bipolar disorder often experience frequent mood alteration attempt controlled mood stabilize agent anti-psychotic agent . Both class medication numerous significant side effect . Establishing ramelteon helpful sleep patient bipolar disorder helpful mood stability increase number treatment option bipolar patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>1 . Provision write informed consent initiation studyrelated procedure 2 . Men woman age 18 65 year . 3 . A documented clinical diagnosis accord DSMIV ( Diagnostic Statistical Manual Mental Disorders , 4th edition , text revision ) meeting criterion 296.4x Bipolar I disorder , recent episode manic , 296.6x Bipolar I disorder , recent episode mix , 296.5x Bipolar I disorder , recent episode depress . 4 . PSQI total score &gt; =5 . 5 . MADRS total score &lt; =12 . 6 . YMRS total score &lt; = 12 7 . Female patient childbearing potential must negative urine pregnancy test enrollment willing use reliable method birth control , i.e. , doublebarrier method , oral contraceptive , implant , dermal contraception , longterm injectable contraceptive , intrauterine device tubal ligation , study . 8 . Be able understand comply requirement study , judge investigator . 9 . Outpatient status enrollment . 1 . Patients diagnosis DSMIV Axis II disorder major impact patient 's current psychiatric status . 2 . Presence prohibit medication antidepressant ( include MAOI 's ) systemic corticosteroid . 3 . Patients diagnosis primary insomnia disorder 4 . Patients diagnosis severe chronic obstructive pulmonary disease 5 . A clinical finding untreated ( eg , hypertension , poorly control diabetes , angina ) , opinion investigator , would negatively affect study medication would affect study medication . 6 . Patients active substance abuse diagnosis ( except tobacco abuse ) . 7 . Known history intolerance hypersensitivity ramelteon component tablet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>